Skip to main content
Clinical Trials/NCT02218528
NCT02218528
Completed
Not Applicable

An Exploratory Study of a Plant-based Ingredient for Reducing the Post-prandial Blood Glucose Response in Healthy Indian Adults, When Administered With a Meal

Unilever R&D1 site in 1 country48 target enrollmentAugust 2014
ConditionsHealthy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy
Sponsor
Unilever R&D
Enrollment
48
Locations
1
Primary Endpoint
Positive incremental post-prandial blood glucose area unde the curve
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The study is designed to determine the extent to which a plant-based ingredient is able to modulate blood glucose response when administered with a meal.

Registry
clinicaltrials.gov
Start Date
August 2014
End Date
September 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Unilever R&D
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Healthy males and females, age at start of the study ≥ 18 and ≤ 50 years;
  • Apparently healthy: no medical conditions which might affect the study measurements, as judged by study physician and/or measured by questionnaire, and/or assessed by haematology, blood chemistry and urinalysis;
  • Fasting blood glucose value of subjects is ≥ 3.4 and ≤ 6.1 mmol/litre (i.e. 62-110 mg/dl) at screening;
  • Haemoglobin level within clinically acceptable range (for male 12 to 17 gm/dL and for females 11 to 15 gm/dL; both inclusive) as judged by the research physician;
  • Body mass index (BMI) ≥ 18,0 and ≤ 25,0 kg/m2;
  • Agreeing to be informed about medically relevant personal test-results by study physician;
  • Willing to comply to study protocol during study;
  • Willing to refrain from drinking of alcohol on and one day before the blood withdrawal;
  • Accessible veins on arms as determined by examination at screening;
  • Being literate;

Exclusion Criteria

  • Any history of diabetes, hyper- (or hypo-) glycemia or other disorder of glucose metabolism;
  • Any history of gastro-intestinal disorders (including frequent diarrhoea for example);
  • Blood donation in the past 2 months;
  • Reported participation in another nutritional or biomedical trial 3 months before the pre-study examination or during the study;
  • Reported participation in night shift work two weeks prior to pre-study investigation or during the study. Night work is defined as working between 23.00 PM and 6.00 AM;
  • Reported intense sporting activities \> 10h/w;
  • Consumption of ≥120 ml of alcoholic drinks for males and females in a typical week;
  • Drug abuse as indicated by urine analysis;
  • Chronic smokers, tobacco chewers and drinkers;
  • Use of any medication, including supplements and traditional medicine;

Outcomes

Primary Outcomes

Positive incremental post-prandial blood glucose area unde the curve

Time Frame: 120 minutes

Secondary Outcomes

  • Positive incremental post-prandial blood glucose area under the curve(180 minutes)
  • Post-prandial insulin response(180 minutes)
  • Assessment of gastric emptying rate(10 hours)

Study Sites (1)

Loading locations...

Similar Trials